The demand for EDTA tubes is surging with increasing preventive diagnostics among the populace in the Asia Pacific region!

The EDTA tube market in the Asia Pacific is expected to witness significant CAGR growth during the forecast period. The primary factors driving this growth are the rising population with an equally rising aging population who requires more frequent medical attention. Furthermore, with the rising income levels of the populace in these regions, people are upgrading their lifestyles which has increased health consciousness and awareness and has given a surge to the demand for preventive care and wellness which is further stimulated by COVID-19. Moreover, spreading healthcare services, expanding healthcare infrastructure, and rising insurance penetration are also contributing to the growth of this industry. Additionally, there has been an increase in the reporting of chronic and lifestyle diseases due to sedentary lifestyle, and bad environmental and pollution conditions in these emerging economies have led to an increase in medical conditions among a large portion of the population and especially in urban regions where affordability is not an issue, and driving up the demand for the medical services which in turn is boosting the demand for the EDTA tubes in these regions. For instance, in February 2023, as per the Department of Biotechnology, India, Chronic or Non-communicable diseases are on the rise across the globe accounting for 73% of all deaths. In India, non-communicable diseases account for 53% of all deaths and 44 % of disability-adjusted life-years lost. India has the highest number of people with Diabetes in the world with around 77 million living with diabetes and a projection of 134 million by 2045 (International Diabetes Federation). India suffers loss of life at an early age due to cardiovascular disease which accounts for one-fourth of all deaths.

Access sample report (including graphs, charts, and figures) – https://univdatos.com/get-a-free-sample-form-php/?product_id=44416

The Asia Pacific EDTA tubes market is expected to grow at a strong CAGR of around 7.5% during the forecast period (2022-2030). The factor driving this growth region is the high population with an increasingly aging population along with high life expectancy. Furthermore, rising disposable income and increasing health consciousness are further contributing to the growth of the EDTA tube market in the Asia Pacific region.

FIG. 1 Asia Pacific EDTA Tubes Market Revenue (2020-2030)- USD Mn

For a detailed analysis of the Global EDTA Tube Market browse through – https://univdatos.com/report/edta-tube-market/

“Amongst additives used, the K2 EDTA segment held a dominating share of the market”

Based on the additives used, the market is bifurcated into K2 EDTA and K3 EDTA. The K2 EDTA is anticipated to witness significant CAGR during the forecast period owing to the fact that K2 EDTA is preferred over K3 EDTA because it is more hypertonic and causes erythrocyte dehydration and shrinkage. Furthermore, another drawback of K3 EDTA is it is a liquid anticoagulant that results in the dilution of the blood specimen, which lowers most of the measurement including RBC, WBC, platelet, MCV, and hemoglobin.

Global EDTA Tubes Market Segmentation

Market Insights, by Additives Used

· K2 EDTA

· K3 EDTA

Market Insights, by Capacity

· <2ml

· 2ml-4ml

· 6ml

· >6ml

Market Insights, by Application

· Complete Blood Count (CBC)

· Blood Smear

· Coagulation Tests

· Bone Marrow Biopsy

· Others

Market Insights, by End-User Industry

· Hospitals

· Diagnostics Centres

· R&D Centres

· Others

Market Insight, by Region

· North America

o U.S.

o Canada

o Rest of North America

· Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Rest of Europe

· APAC

o China

o India

o Japan

o Australia

o South Korea

o Rest of APAC

· Rest of the World

Top Company Profiles

· Vitrex Medical

· HWTAI

· VACUTEST KIMA S.r.l

· Disera Tıbbi Malzeme Lojistik Sanayi ve Ticaret A.Ş

· WEGO Medical International Trade Co., Ltd.

· Advin Health Care

· Apex Bio Medicals

· Proexamine Surgicals Pvt. Ltd.

· Medis Medical

· VWR International, LLC